Analysis of Distress in Patients with Gynecological Cancers During the COVID-19 Pandemic: A Telephone Survey
Received: 07 Jul 2021 | Received in revised form: 29 Nov 2021
Accepted: 09 Aug 2022 | Available online: 16 Aug 2022Adem YAVUZa, Mehmet DOLANBAYb, Emine Fusun AKYÜZ ÇİMc, Ayşe DİŞLİ GÜRLERd, Cevat Fırat CÜNDÜBEYe
aDepartment of Obstetrics and Gynecology, Ömer Halisdemir University Faculty of Medicine, Niğde, Türkiye
bDepartment of Obstetrics and Gynecology, Erciyes University Faculty of Medicine, Kayseri, Türkiye
cDepartment of Psychiatry, Demiroğlu Bilim University Medical Faculty, İstanbul Florence Nightingale Hospital, İstanbul, Türkiye
dClinic of Obstetrics and Gynecology, Şanlıurfa Training and Research Hospital, Şanlıurfa, Türkiye
eClinic of Obstetrics and Gynecology, Kayseri Training and Research Hospital, Kayseri, Türkiye
JCOG. 2022;32(3):93-9
DOI: 10.5336/jcog.2021-85352
Article Language: EN
Copyright Ⓒ 2024 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (
http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: To investigate distress levels in patients with gynaecological cancers during the coronavirus disease-2019 (COVID-19) pandemic and identify factors associated with distress. Material and Methods: A total of 193 patients who underwent cytoreductive surgery for gynaecological cancer were included in our research. The patients were contacted by phone and provided detailed information about our study and the questionnaire that was to be applied. We performed distress screening using The National Comprehensive Cancer Network Distress Thermometer and Problem List (PL), developed for cancer patients. Results: In the study group, 51% of patients were categorized in the high-stress group. As practical problems, childcare (p<0.001), insurance/financial (p<0.033), work/school (p<0.001), treatment decisions (p<0.001), have significant differences between 2 groups in the present study. As family problems dealing with children (p<0.001), family health issues (p<0.014) have significant differences between the low-stress group and the high-stress group. All the emotional parameters evaluated by PL questionnaire have significant difference between the groups. The emotional significance levels of the parameters are as follows: depression (p<0.001), fears (p<0.001), nervousness (p<0.002), sadness (p<0.001), worry (p<0.012), loss of interest (p<0.001). Conclusion: Our results send a message to the gynaecological cancer healthcare world about what conditions may plague the gynaecological cancer patient in COVID-19 pandemic. Identifying problem areas for patients in our study constitutes the first step in the intervention.
REFERENCES:- Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;277:55-64. [Crossref] [PubMed] [PMC]
- Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021;9(3):e002266. [Crossref] [PubMed] [PMC]
- Gultekin M, Ak S, Ayhan A, Strojna A, Pletnev A, Fagotti A, et al. Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: a Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe). Cancer Med. 2021;10(1):208-19. [Crossref] [PubMed] [PMC]
- National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Distress management (v.2.2018): Pennsylvania: NCCN; 2018. Cited: December 1, 2020. Available from: [Link]
- Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82(10):1904-8. [Crossref] [PubMed]
- Ozalp E, Cankurtaran ES, Soygür H, Geyik PO, Jacobsen PB. Screening for psychological distress in Turkish cancer patients. Psychooncology. 2007;16(4):304-11. [Crossref] [PubMed]
- Ownby KK. Use of the distress thermometer in clinical practice. J Adv Pract Oncol. 2019;10(2):175-9. [Crossref] [PubMed] [PMC]
- Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragon N. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020;36(4):e00054020. [Crossref] [PubMed]
- Nwachukwu I, Nkire N, Shalaby R, Hrabok M, Vuong W, Gusnowski A, et al. COVID-19 pandemic: age-related differences in measures of stress, anxiety and depression in Canada. Int J Environ Res Public Health. 2020;17(17):6366. [Crossref] [PubMed] [PMC]
- Juanjuan L, Santa-Maria CA, Hongfang F, Lingcheng W, Pengcheng Z, Yuanbing X, et al. Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study. Clin Breast Cancer. 2020;20(5):e651-62. [Crossref] [PubMed] [PMC]
- Romito F, Dellino M, Loseto G, Opinto G, Silvestris E, Cormio C, et al. Psychological distress in outpatients with lymphoma during the COVID-19 pandemic. Front Oncol. 2020;10:1270. [Crossref] [PubMed] [PMC]
- Banerjee D, Rai M. Social isolation in Covid-19: the impact of loneliness. Int J Soc Psychiatry. 2020;66(6):525-7. [Crossref] [PubMed] [PMC]
- Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage. 2008;35(6):644-55. [Crossref] [PubMed]
- Tran BX, Ha GH, Nguyen LH, Vu GT, Hoang MT, Le HT, et al. Studies of novel coronavirus disease 19 (COVID-19) pandemic: a global analysis of literature. Int J Environ Res Public Health. 2020;17(11):4095. [Crossref] [PubMed] [PMC]
- Swainston J, Chapman B, Grunfeld EA, Derakshan N. COVID-19 lockdown and its adverse impact on psychological health in breast cancer. Front Psychol. 2020;11:2033. [Crossref] [PubMed] [PMC]